Bravura FY26 slides: EBITDA surges 76% as margins expand to 27%

Bravura (ASX:BVS) delivered FY26 cash EBITDA of $77.1m (+76% YoY) on revenue up 10% to $283.6m, with underlying NPAT rising 158.6% to $63.1m. The company expanded its cash EBITDA margin to 27.3% (approaching ~30% in 2H), supported by cost discipline (operating costs down 3.8% to $200.2m) and net operating cash inflow of $82.8m (+$38.4m). Capital returns were substantial—dividends of $113.2m and ongoing shareholder payouts—while shares jumped 15.4% to $3.22. FY27 guidance calls for gross revenue of $280–$300m and cash EBITDA of $84–$94m (9–22% growth), implying a ~30% midpoint margin, despite a modest FX headwind (1.90 AUD:1.00 GBP assumed).

Analysis

The rerate case is less about top-line acceleration than proof that the cost base has been reset and can now throw off cash at a higher margin. That matters because a business with concentrated, sticky renewals can support a much higher multiple once investors believe the earnings are recurring, but it also means upside is now more dependent on share buybacks and sentiment than on organic growth. The immediate beneficiaries are shareholders and, secondarily, pure software peers with similar renewal-heavy models such as SS&C and SimCorp; the losers are labor-intensive outsourcing/admin models where the UK shift toward software-only procurement could compress pricing power.

Near term, the stock can still drift higher over the next 1-3 months as buyback demand meets a light float and management reiterates guidance. The real catalyst to watch is whether the next renewal cycle converts pricing gains into net retention without another material customer loss; if not, the market will quickly reclassify this as a one-year margin reset rather than a durable compounding story. The debt-funded buyback is supportive, but it also makes the equity more sensitive to any working-capital wobble or FX drag in the UK book.

Contrarianly, consensus may be underestimating how much of the margin expansion is already in the price after a 15% jump. FY27 revenue guidance implies only low-growth economics, so multiple expansion needs to do the heavy lifting; that is fragile if a single large client renegotiates harder or if implementation issues delay project revenue. I would treat this as a quality turnaround rather than a new growth engine, with falsification coming from gross revenue below the low end of guidance, EBITDA margin slipping back under the high-20s, or the buyback being paused because cash conversion weakens.

Key Decisions for Investors

• ASX:BVS / BVSFF: buy on a 5-8% pullback, not chase strength; target another 10-15% upside over 1-3 months if the buyback is executed and management reaffirms FY27 margin expansion. Stop if gross revenue trends toward the low end of guidance or net retention deteriorates.
• Pair trade: long ASX:BVS versus short a basket of outsourcing-heavy wealth/admin software names or local IT-services proxies that rely on headcount leverage; thesis is software-only pricing power versus lower-quality service revenue. Monitor for evidence that customer preference is shifting toward software-only contracts.
• For options-capable accounts, sell out-of-the-money puts on BVSFF/ASX:BVS into post-earnings strength to express a view that the market has over-discounted the turnaround while limiting cash outlay. Risk is a renewed customer loss or FX-driven guidance cut.
• Alert item: if the next quarterly/half-year update shows cash conversion slipping or the buyback pace slowing, exit the bullish view; that would indicate the capital-return story is substituting for, rather than amplifying, underlying operating momentum.